Rhythmic Contractions of Lymph Vessels and Lymph Flow Are Disrupted in Hypertensive Rats
Soumiya Pal1, Ashim K Bagchi1, David S Henry2
1Department of Pharmaceutical Sciences, College of Pharmacy (S.P., A.K.B., A.J.S.), University of Arkansas for Medical Sciences, Little Rock, AR.
Hypertension (Dallas, Tex. : 1979)
|November 6, 2024
Summary
Hypertension impairs lymphatic vessel function and reduces lymph flow. This dysfunction may stem from a loss of specific potassium channels (KV1.2) in lymphatic muscle cells.
Area of Science:
- Cardiovascular Physiology
- Lymphatic Biology
- Renal Physiology
Background:
- Hypertension is a known risk factor for lymphedema.
- The direct impact of hypertension on lymphatic vessel (LV) function and lymph flow remains unclear.
- This study investigates the effects of hypertension on lymphatic contractility and lymph transport.
Purpose of the Study:
- To compare mesenteric LV function and lymph flow in hypertensive versus normotensive rats.
- To elucidate the ionic mechanisms underlying hypertensive lymphatic contractile dysfunction.
- To examine the expression of ion channel proteins in hypertensive lymphatic vessels.
Main Methods:
- Ex vivo assessment of mesenteric LV contractions and in vivo measurement of mesenteric lymph flow using video microscopy and optical imaging.
- Induction of hypertension using angiotensin II (Ang II) and utilization of spontaneously hypertensive rats.
- Jess capillary Western electrophoresis to evaluate ion channel protein expression.
Main Results:
- Hypertensive LVs exhibited dysrhythmic contractions, reduced diastolic diameters, and decreased cross-sectional flow.
- Mesenteric lymph flow was significantly lower (2.9-fold) in Ang II-induced hypertensive rats.
- A loss of intact L-type Ca2+ channel proteins and Shaker-type KV1.2 channels was observed in hypertensive LVs.
Conclusions:
- Hypertension leads to lymphatic contractile dysfunction and compromised lymph flow.
- The observed lymphatic dysfunction in hypertension may be attributed to a reduction in KV1.2 channels in lymphatic muscle cells.
- This provides initial evidence linking hypertension-induced ion channel changes to lymphatic impairment.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
461
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
461
Antihypertensive Drugs: Angiotensin II Receptor Blockers
590
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
590
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
482
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
482


